The Effect of Oxytocin (OT) and Oxytocin Plus Human Chorionic Gonadotropin (hCG), in Cycles Induced by Letrozole or Clomiphene Citrate
NCT00844350 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 177
Last updated 2009-02-16
Summary
The specific aims of this study were to assess whether letrozole as an aromatase inhibitor plus hCG or OT alone, or in combination compared with CC, improves ovarian response.Ethical design of this study is based on the ethical guidelines of the Iranian Medical and Health Ministry which is accepted by Tabriz medical university ethical committee .
Conditions
- Ovarian Response
Interventions
- DRUG
-
letrozole , oxytocin,hCG,clomiphene citrate
Sponsors & Collaborators
-
Tabriz University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 17 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2007-09-30
- Completion
- 2007-10-31
More Related Trials
-
Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF
NCT02201914 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle
NCT07028710 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination
NCT01232075 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
NCT04268927 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
NCT04727684 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
NCT02436226 ·Status: COMPLETED ·Phase: PHASE4
-
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
NCT05143723 ·Status: UNKNOWN ·Phase: PHASE2
-
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome
NCT06812559 ·Status: COMPLETED
-
The Letrozole Administration During Luteal Phase
NCT02686151 ·Status: UNKNOWN ·Phase: PHASE3
-
Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles
NCT00485537 ·Status: COMPLETED ·Phase: NA
-
Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET
NCT01219153 ·Status: COMPLETED ·Phase: PHASE2
-
Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients
NCT02293668 ·Status: COMPLETED ·Phase: NA
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Letrozole Versus Clomifene Citrate for Ovulation Induction
NCT00478504 ·Status: COMPLETED ·Phase: PHASE4
-
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
NCT05838105 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome
NCT00947713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI
NCT04724486 ·Status: COMPLETED ·Phase: PHASE4
-
Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)
NCT02392520 ·Status: UNKNOWN ·Phase: NA
-
The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
NCT04308343 ·Status: UNKNOWN ·Phase: NA
-
Use of Letrozole for Ectopic Pregnancy
NCT06354439 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females
NCT00796289 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response
NCT02798653 ·Status: UNKNOWN ·Phase: PHASE3
-
GnRH Agonist and Antagonists in an Oocyte Donation Program
NCT00505817 ·Status: COMPLETED ·Phase: PHASE4
-
Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger
NCT03044756 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol
NCT06367712 ·Status: COMPLETED ·Phase: PHASE1